HOME >> BIOLOGY >> NEWS
Mouse model of schizophrenia could speed identification of new antipsychotic drugs

Howard Hughes Medical Institute researchers have produced a genetically altered mouse that exhibits behavioral abnormalities that are strikingly similar to those observed in humans with schizophrenia.

The scientists report that they have already used insights from studying the mouse to identify a genetic variant associated with schizophrenia in humans.

According to the researchers, the findings could well mean that they have identified a molecular signaling pathway involved in the origin of schizophrenia, which affects about one percent of the population. If so, the search for drugs affecting that pathway could yield a new class of antipsychotic drugs that more precisely and effectively treat the disorder.

The researchers, led by Howard Hughes Medical Institute investigator Susumu Tonegawa at the Massachusetts Institute of Technology, published their findings June 30, 2003, in two articles in the early edition of the Proceedings of the National Academy of Sciences (PNAS). Tonegawa collaborated on the studies with researchers from Duke University Medical Center, The Rockefeller University and the Columbia University College of Physicians and Surgeons.

In their latest studies, Tonegawa and his colleagues built on their earlier research on a genetically engineered mouse, which had been specifically altered to knock out the gene for the enzyme calcineurin only in the animal's forebrain. Calcineurin is an enzymatic switch that plays regulatory roles in both the immune system and the brain. Until a brain-specific knockout mouse was developed in Tonegawa's laboratory, it had not been possible to pinpoint the enzyme's function in the brain. In earlier studies, Tonegawa and his colleagues found that the mutant mouse showed severe, specific deficits in a type of short-term memory called working memory.

Although schizophrenics show similar memory deficits, sai
'"/>

Contact: Avice Meehan
meehana@hhmi.org
301-215-8855
Howard Hughes Medical Institute
30-Jun-2003


Page: 1 2 3

Related biology news :

1. Half-million dollar landmark achieved for the Methuselah Mouse Prize
2. Mouse study shows NPAS3 and NPAS1 genes may be linked to psychosis
3. Mouse brain stem cells capable of converting into blood vessel cells
4. Mouse study yields clue to why liver is less prone to rejection, say Pitt researchers
5. Mouse embryonic germ cells and male gametes created in the lab
6. Mouse, stripped of a key gene, resists diabetes
7. Mouse study identifies protective mechanism against alcohol-induced embryo toxicity
8. Mouse model offers new explanation for kidney disease and failure
9. Mouse study suggests mammoth evolutionary change
10. Mouse genetic model for spongiform brain diseases
11. Mouse model links alcohol intake to marijuana-like brain compounds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... January 24, 2020 , ... The Rockies ... capital resources to support early-stage bioscience companies in the state. , ... to find the funding they need to innovate and grow. This program ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... red blood cells from stem cells. The red blood cells are made ... strictly controlled conditions, for transfusion therapy and replaces the need for a human ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, ... a consortium of over 100 partner organizations from industry, government, academia and ...
Breaking Biology News(10 mins):
(Date:12/31/2019)... ... December 31, 2019 , ... Vici Health ... development lab in Maryland. Emphasis will be in expanding capabilities in both ... Health Sciences will be well positioned to meet the growing demand for its ...
(Date:12/27/2019)... ... December 27, 2019 , ... Vici Health Sciences is announcing ... that offers patients and healthcare providers options in the treatment of chronic ... with doctors and managed care professionals and developed at Vici’s R&D facility ...
(Date:12/18/2019)... ... , ... Tune in to CNBC on Saturday, December 28th at 11:00aET to ... more information on this program. , With a look at Avatar Partners , ... to increase the efficiency, safety and effectiveness of equipment, systems, and processes for the ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... and services, today announced a partnership with the Recombinant Antibody Network (RAN), a ... and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies ...
Breaking Biology Technology:
Cached News: